TrialAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2023

Vericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary Syndromes.

Michael Böttcher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.